221 related articles for article (PubMed ID: 16435073)
1. Microarray analysis of promoter methylation in lung cancers.
Fukasawa M; Kimura M; Morita S; Matsubara K; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Sasaki H; Hatada I
J Hum Genet; 2006; 51(4):368-374. PubMed ID: 16435073
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
3. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
5. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
6. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
8. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
Shah JN; Shao G; Hei TK; Zhao Y
BMC Cancer; 2008 Oct; 8():284. PubMed ID: 18834524
[TBL] [Abstract][Full Text] [Related]
9. [Effect of adenomatous polyposis coli(APC) promoter methylation on gene transcription in lung cancer cell lines].
Zhang LX; Pan SY; Chen D; Xie EF; Gao L; Shu YQ; Lu ZH; Cheng L; Yang D; Zhang JN
Ai Zheng; 2007 Jun; 26(6):576-80. PubMed ID: 17562260
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of promoter methylation in human.
Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
[TBL] [Abstract][Full Text] [Related]
11. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
[TBL] [Abstract][Full Text] [Related]
12. Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.
Sun W; Iijima T; Kano J; Kobayashi H; Li D; Morishita Y; Okubo C; Anami Y; Noguchi M
Cancer Sci; 2008 Nov; 99(11):2177-84. PubMed ID: 18823374
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
[TBL] [Abstract][Full Text] [Related]
14. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
[TBL] [Abstract][Full Text] [Related]
18. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
19. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
